Michael Coe

Company: Phoreus Biotech

Job title: Chief Scientific Officer


Peptide Nanoparticle (PNP) Delivery Platforms for the Next Generation of RNA Vaccines and Therapeutics 9:30 am

The peptides in our PNPs do not stimulate the innate immune system and are less toxic to cells and tissues than lipid nanoparticle formulations PNP/mRNA conjugates are structurally and functionally compatible with both freeze dried and spray dried formulations Our carefully constructed patent protections provide a clear path for licensing and utilization of Phoreus PNP…Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.